[Drug-resistant epilepsy].
Arroyo
S
S
Servicio de Anatomía Patológica, Hospital Clínic de Barcelona, España.
Rumiá
J
J
Martínez
I
I
Ribalta
T
T
D000328:Adult; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D002114:Calcinosis / Q000175:diagnosis; D002220:Carbamazepine / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D005260:Female; D005910:Glioma / Q000145:classification; D006801:Humans; D008279:Magnetic Resonance Imaging; D009373:Neoplasms, Germ Cell and Embryonal / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D018302:Neoplasms, Neuroepithelial / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D010672:Phenytoin / Q000008:administration & dosage / Q000627:therapeutic use; D013702:Temporal Lobe / Q000473:pathology* / Q000601:surgery; D015899:Tomography, Emission-Computed, Single-Photon; D014635:Valproic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use
D000927:Anticonvulsants; D002220:Carbamazepine; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D010672:Phenytoin; D020888:Vigabatrin
Epilepsia farmacorresistente.